James E Norton Selected Research

James E Norton Research Topics

Disease

19	Rhinosinusitis 01/2023 - 04/2013
16	Nasal Polyps (Nasal Polyp) 01/2023 - 04/2013
5	Asthma (Bronchial Asthma) 01/2021 - 03/2015
4	Inflammation (Inflammations) 01/2023 - 04/2013
3	Polyps 11/2022 - 01/2017
3	Neoplasms (Cancer) 03/2021 - 01/2019
3	Infections 01/2016 - 08/2013
2	Hypersensitivity (Allergy) 03/2024 - 03/2015
2	Eosinophilia 01/2017 - 09/2015
1	Anaphylaxis (Anaphylactic Shock) 03/2024
1	Carcinoma (Carcinomatosis) 03/2024
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 03/2024
1	Sepsis (Septicemia) 02/2023
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Bacterial Infections (Bacterial Infection) 12/2017
1	Eosinophilic Esophagitis 09/2015
1	Airway Remodeling 04/2015
1	Rabies (Hydrophobia) 08/2013
1	Lung Injury 09/2007
1	Pulmonary Edema 09/2007

Drug/Important Bio-Agent (IBA)

6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 06/2014
5	Proteins (Proteins, Gene)FDA Link 02/2023 - 04/2013
3	CytokinesIBA 02/2023 - 01/2014
3	Biomarkers (Surrogate Marker)IBA 02/2023 - 09/2017
3	FibrinIBA 11/2022 - 12/2019
3	VaccinesIBA 03/2021 - 08/2013
3	AntibodiesIBA 07/2017 - 04/2013
3	Messenger RNA (mRNA)IBA 01/2017 - 09/2015
2	Oncostatin MIBA 01/2023 - 06/2017
2	Cyclooxygenase 1IBA 01/2021 - 01/2021
2	AllergensIBA 06/2017 - 09/2015
2	Adenosine Triphosphatases (ATPase)IBA 01/2017 - 09/2007
2	ErbB Receptors (EGF Receptor)IBA 01/2017 - 04/2015
1	acalabrutinibIBA 03/2024
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2024
1	Agammaglobulinaemia Tyrosine KinaseIBA 03/2024
1	LipidsIBA 02/2023
1	Angiopoietin-2IBA 02/2023
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 02/2023
1	Interleukin-4 (Interleukin 4)IBA 01/2023
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 01/2023
1	SubtilisinIBA 01/2023
1	Thymic Stromal LymphopoietinIBA 01/2023
1	fibrin fragment D (D-dimer)IBA 11/2022
1	RetinoidsIBA 11/2022
1	Plasminogen Activators (Plasminogen Activator)IBA 11/2022
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2022
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 01/2021
1	Arachidonic Acid (Vitamin F)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	IntegrinsIBA 12/2020
1	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 12/2019
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2019
1	Immunoglobulin D (IgD)IBA 12/2017
1	Complement System Proteins (Complement)IBA 07/2017
1	Staphylococcal Protein A (Protein A)IBA 07/2017
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 07/2017
1	Leukocyte Elastase (Neutrophil Elastase)IBA 06/2017
1	Interleukin-13IBA 01/2017
1	EpiregulinIBA 01/2017
1	Chemokine CCL26IBA 01/2017
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 01/2017
1	Proton Pump InhibitorsIBA 01/2017
1	LigandsIBA 01/2017
1	Poly I-CIBA 01/2016
1	Filaggrin ProteinsIBA 05/2015
1	Toll-Like Receptor 2IBA 04/2015
1	AutoantigensIBA 03/2015
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2014
1	OvalbuminIBA 08/2013
1	Neutralizing AntibodiesIBA 08/2013
1	HLA-DR Antigens (HLA-DR)IBA 08/2013
1	Interleukin-2 (IL2)IBA 08/2013
1	EndotoxinsIBA 09/2007

Therapy/Procedure

3	Therapeutics 02/2023 - 01/2019
1	Immunotherapy 03/2021
1	Immunomodulation 01/2021
1	Transplantation 01/2019